Dr. Vicentini, an associate of the endourology unit from the University of Sao Paulo, and head of the endourology unit at Brigadeiro Hospital begins by stating that the supine position should be favored. He states that one has to try supine to understand, he says “If you are not convinced that supine is better, I guarantee you that if you start doing supine, in few months most of your cases will be done in supine.” Ever since his hospital tried using the supine position in 2014, the rate of prone PCNL is now 0%. He provides evidence that when a hospital begins trying the supine PCNL, it becomes the new standard. He states that the outcomes between prone versus supine PCNL are similar, that supine is feasible and simply easier to do.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Dr. Vincentini, the proponent of supine PCNL, finishes the debate by stating that there are no differences in complications, the difference in stone-free rates a minor (78% vs 72%), the supine position provides quicker, less bloody, less supracostal punctures and a high success rate even for complicated anatomy or complex cases.
Presented by: Michael Lipkin, Duke University Medical Center; Fabio Vicentini, University of Sao Paulo & Brigadeiro Hospital
Plenary Chairs: Ben H. Chew, University of British Columbia; Kenneth T. Pace, St. Michael's Hospital, University of Toronto
Session Chair: James Lingeman, Indiana University School of Medicine
Written by Egor Parkhomenko, Department of Urology, University of California-Irvine at the 35th World Congress of Endourology– September 12-16, 2017, Vancouver, Canada.